These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 35003514)
1. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines. Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514 [TBL] [Abstract][Full Text] [Related]
2. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
3. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives. Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators. Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307 [TBL] [Abstract][Full Text] [Related]
5. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity. Farghaly TA; Masaret GS; Muhammad ZA; Harras MF Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities. Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898 [TBL] [Abstract][Full Text] [Related]
8. Green, facile synthesis and evaluation of unsymmetrical carbamide derivatives as antimicrobial and anticancer agents with mechanistic insights. Sroor FM; Soliman AAF; Youssef EM; Abdelraof M; El-Sayed AF Sci Rep; 2024 Jul; 14(1):15441. PubMed ID: 38965246 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers. Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells. Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320 [TBL] [Abstract][Full Text] [Related]
15. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer. Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811 [TBL] [Abstract][Full Text] [Related]
16. New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents. Sobh EA; Kassab AE; El-Khouly EA; S A Hassan M Bioorg Chem; 2024 Mar; 144():107158. PubMed ID: 38301427 [TBL] [Abstract][Full Text] [Related]
17. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies. Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site. Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt. Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, photophysical properties, anticancer evaluation, and molecular docking studies of new pyrimidine linked 4-arylidene-thiazolidin-4-ones as potent anticancer agents. Jame R Luminescence; 2024 Jan; 39(1):e4672. PubMed ID: 38286597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]